NYSE:DGX
Quest Diagnostics
- Stock
Last Close
176.51
06/11 21:10
Market Cap
15.60B
Beta: 0.94
Volume Today
857.29K
Avg: 1.14M
PE Ratio
16.23
PFCF: 23.35
Dividend Yield
2.29%
Payout:36.18%
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 100.50M - | 97M 3.48% | 83M 14.43% | 88.50M 6.63% | 97M 9.60% | 111M 14.43% | 173M 55.86% | 215.50M 24.57% | 200M 7.19% | ||
average payables | 257.50M - | 268M 4.08% | 270M 0.75% | 242.50M 10.19% | 223M 8.04% | 242.50M 8.74% | 354.50M 46.19% | 401.50M 13.26% | 340.50M 15.19% | ||
average receivables | 892M - | 916.50M 2.75% | 913.50M 0.33% | 925M 1.26% | 968M 4.65% | 1.04B 7.18% | 1.29B 24.48% | 1.48B 14.52% | 1.32B 10.99% | ||
book value per share | 29.66 - | 32.53 9.66% | 33.06 1.63% | 35.92 8.66% | 38.35 6.77% | 21.05 45.12% | 50.44 139.64% | 51.55 2.20% | 50.80 1.46% | ||
capex per share | -2.12 - | -1.83 14.02% | -2.09 14.59% | -1.84 12.11% | -2.82 53.10% | -1.49 47.00% | -3.12 109.00% | -3.22 3.35% | -3.48 8.03% | -3.64 4.60% | |
capex to depreciation | -0.98 - | -0.87 11.80% | -1.18 36.01% | -0.93 20.68% | -1.24 32.80% | -1.22 1.91% | -1.16 4.76% | -0.99 14.69% | -0.92 6.40% | -0.93 0.53% | |
capex to operating cash flow | -0.33 - | -0.32 1.12% | -0.27 15.59% | -0.21 21.75% | -0.32 48.82% | -0.32 0.83% | -0.21 35.22% | -0.18 13.43% | -0.24 30.30% | -0.32 36.40% | |
capex to revenue | -0.04 - | -0.04 15.27% | -0.04 11.08% | -0.03 16.16% | -0.05 55.58% | -0.05 1.80% | -0.04 14.45% | -0.04 15.66% | -0.04 9.43% | -0.04 7.88% | |
cash per share | 1.32 - | 0.92 30.25% | 2.56 177.64% | 1 61.00% | 0.99 0.74% | 4.45 348.07% | 8.64 94.30% | 6.98 19.28% | 2.72 61.07% | ||
days of inventory on hand | 8.66 - | 6.58 23.96% | 6.48 1.51% | 7.35 13.32% | 7.34 0.17% | 8.91 21.50% | 14.02 57.34% | 11.54 17.71% | 10.87 5.85% | ||
days payables outstanding | 20.23 - | 21.87 8.09% | 20.64 5.62% | 17.33 16.05% | 16.45 5.06% | 19.06 15.86% | 28.05 47.17% | 19.81 29.38% | 18.33 7.43% | ||
days sales outstanding | 45.75 - | 43.89 4.07% | 44.98 2.47% | 43.75 2.73% | 49.05 12.11% | 50.22 2.39% | 58.79 17.07% | 48.65 17.24% | 44.13 9.29% | ||
debt to assets | 0.38 - | 0.37 3.78% | 0.37 0.88% | 0.36 2.55% | 0.35 1.79% | 0.41 17.25% | 0.33 20.00% | 0.34 3.09% | 0.36 5.23% | ||
debt to equity | 0.87 - | 0.78 10.89% | 0.81 3.51% | 0.77 4.69% | 0.75 2.94% | 0.94 26.55% | 0.69 27.08% | 0.72 4.93% | 0.78 8.53% | ||
dividend yield | 0.02 - | 0.02 7.61% | 0.02 16.25% | 0.02 5.61% | 0.02 28.31% | 0.01 57.46% | 0.02 86.12% | 0.01 23.18% | 0.02 17.63% | 0.02 20.98% | |
earnings yield | 0.06 - | 0.07 21.04% | 0.05 27.57% | 0.06 14.13% | 0.06 13.59% | 0.03 53.87% | 0.09 198.91% | 0.09 2.94% | 0.05 43.49% | 0.06 6.08% | |
enterprise value | 13.29B - | 13.76B 3.52% | 16.24B 18.01% | 17.14B 5.54% | 15.08B 12.00% | 32.76B 117.17% | 19.47B 40.57% | 25.41B 30.54% | 22.45B 11.64% | ||
enterprise value over ebitda | 10.02 - | 8.82 11.94% | 11.94 35.37% | 11.81 1.08% | 10.73 9.19% | 20.73 93.26% | 8.08 61.01% | 8.05 0.46% | 12.41 54.17% | ||
ev to operating cash flow | 14.17 - | 16.99 19.88% | 15.19 10.58% | 14.59 3.98% | 12.57 13.84% | 26.35 109.66% | 9.71 63.16% | 11.38 17.21% | 13.07 14.85% | ||
ev to sales | 1.79 - | 1.84 2.72% | 2.16 17.67% | 2.22 2.88% | 2.00 9.92% | 4.24 111.69% | 2.06 51.35% | 2.36 14.20% | 2.27 3.55% | ||
free cash flow per share | 4.34 - | 3.80 12.57% | 5.54 45.92% | 6.74 21.55% | 6.01 10.83% | 3.15 47.64% | 11.84 276.51% | 14.64 23.61% | 11.33 22.63% | 7.71 31.90% | |
free cash flow yield | 0.06 - | 0.05 17.59% | 0.06 12.96% | 0.07 13.42% | 0.07 5.46% | 0.03 59.17% | 0.10 237.40% | 0.08 14.85% | 0.07 14.43% | 0.06 22.73% | |
graham net net | -31.73 - | -30.06 5.27% | -30.49 1.44% | -33.51 9.90% | -34.67 3.48% | -18.77 45.88% | -35.26 87.92% | -39.96 13.30% | -47.61 19.16% | ||
graham number | 50.59 - | 60.03 18.66% | 58.54 2.48% | 67.48 15.28% | 68.34 1.26% | 38.94 43.02% | 110.09 182.73% | 136.06 23.59% | 96.55 29.04% | ||
income quality | 1.58 - | 1.08 32.11% | 1.54 42.78% | 1.43 7.16% | 1.52 6.79% | 1.37 9.91% | 1.34 2.51% | 1.07 19.74% | 1.69 57.66% | 1.40 17.24% | |
intangibles to total assets | 0.72 - | 0.69 3.84% | 0.69 0.51% | 0.71 3.15% | 0.71 0.50% | 0.60 14.66% | 0.57 4.89% | 0.61 5.89% | 0.65 6.67% | 0 100% | |
interest coverage | 5.99 - | 9.14 52.55% | 8.93 2.34% | 7.72 13.60% | 6.59 14.55% | 7.03 6.70% | 12.09 71.90% | 15.77 30.40% | 10.35 34.38% | -8.30 180.24% | |
interest debt per share | 27.08 - | 26.42 2.43% | 27.69 4.83% | 28.72 3.72% | 29.85 3.94% | 20.53 31.22% | 35.96 75.10% | 38.46 6.98% | 41.03 6.68% | ||
inventory turnover | 42.15 - | 55.44 31.52% | 56.29 1.54% | 49.67 11.76% | 49.76 0.17% | 40.95 17.70% | 26.03 36.44% | 31.63 21.53% | 33.59 6.21% | ||
invested capital | 0.87 - | 0.78 10.89% | 0.81 3.51% | 0.77 4.69% | 0.75 2.94% | 0.94 26.55% | 0.69 27.08% | 0.72 4.93% | 0.78 8.53% | ||
market cap | 9.72B - | 10.24B 5.35% | 12.87B 25.59% | 13.49B 4.87% | 11.32B 16.07% | 28.62B 152.72% | 15.97B 44.20% | 21.63B 35.43% | 18.15B 16.09% | 15.44B 14.90% | |
net current asset value | -3.94B - | -3.68B 6.74% | -3.83B 4.19% | -4.16B 8.61% | -4.27B 2.57% | -4.59B 7.52% | -4.08B 11.18% | -4.31B 5.67% | -4.93B 14.48% | ||
net debt to ebitda | 2.69 - | 2.26 16.17% | 2.48 10.04% | 2.51 1.28% | 2.67 6.34% | 2.62 2.06% | 1.45 44.52% | 1.20 17.47% | 2.38 98.54% | ||
net income per share | 3.83 - | 4.92 28.40% | 4.61 6.43% | 5.64 22.31% | 5.41 3.96% | 3.20 40.84% | 10.68 233.57% | 15.96 49.45% | 8.16 48.90% | 7.63 6.50% | |
operating cash flow per share | 6.47 - | 5.63 13.05% | 7.64 35.75% | 8.58 12.32% | 8.82 2.88% | 4.64 47.44% | 14.96 222.61% | 17.86 19.39% | 14.81 17.09% | 11.36 23.32% | |
payables turnover | 18.04 - | 16.69 7.49% | 17.69 5.96% | 21.07 19.12% | 22.19 5.33% | 19.15 13.69% | 13.01 32.05% | 18.43 41.61% | 19.91 8.02% | ||
receivables turnover | 7.98 - | 8.32 4.25% | 8.12 2.41% | 8.34 2.80% | 7.44 10.80% | 7.27 2.33% | 6.21 14.58% | 7.50 20.83% | 8.27 10.24% | ||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.20 - | 0.23 15.11% | 0.20 11.28% | 0.25 23.69% | 0.23 10.09% | 0.17 26.14% | 0.24 42.18% | 0.37 56.02% | 0.21 43.95% | ||
revenue per share | 51.28 - | 52.03 1.48% | 53.68 3.16% | 56.27 4.83% | 55.38 1.59% | 28.83 47.94% | 70.43 144.29% | 86.30 22.55% | 85.20 1.28% | 82.61 3.04% | |
roe | 0.13 - | 0.15 17.09% | 0.14 7.93% | 0.16 12.56% | 0.14 10.06% | 0.15 7.79% | 0.21 39.20% | 0.31 46.23% | 0.16 48.15% | ||
roic | 0.08 - | 0.11 31.79% | 0.09 16.83% | 0.10 10.96% | 0.10 5.27% | 0.08 15.28% | 0.12 50.21% | 0.16 26.34% | 0.10 35.55% | ||
sales general and administrative to revenue | 0.23 - | 0.22 3.59% | 0.22 0.17% | 0.23 1.48% | 0.19 16.71% | ||||||
shareholders equity per share | 29.66 - | 32.53 9.66% | 33.06 1.63% | 35.92 8.66% | 38.35 6.77% | 21.05 45.12% | 50.44 139.64% | 51.55 2.20% | 50.80 1.46% | ||
stock based compensation to revenue | 0.01 - | 0.01 1.17% | 0.01 32.30% | 0.01 11.61% | 0.01 20.96% | 0.01 10.51% | 0.01 41.81% | 0.01 28.76% | 0.01 6.39% | 0.01 6.82% | |
tangible asset value | -2.77B - | -2.11B 24.05% | -2.21B 5.03% | -2.42B 9.36% | -2.43B 0.29% | -1.98B 18.51% | -1.15B 41.88% | -1.70B 47.95% | -2.31B 35.59% | ||
tangible book value per share | -19.12 - | -14.63 23.53% | -15.80 8.03% | -17.66 11.75% | -17.84 1.03% | -7.38 58.65% | -8.57 16.24% | -13.60 58.61% | -19.87 46.11% | ||
working capital | -106M - | 328M 409.43% | 550M 67.68% | 249M 54.73% | -95M 138.15% | 500M 626.32% | 1.28B 156.40% | 988M 22.93% | 347M 64.88% |
All numbers in USD (except ratios and percentages)